Patent Application – Dr. Dragieva Nanofat Protocol

On April 30, 2025, our novel nanofat application technique was officially filed for patent with the Swiss Federal Institute of Intellectual Property (Patent pending, Switzerland).

This minimally invasive method is based on autologous fat tissue, where only 20–40 ml of lipoaspirate has the potential to address multiple aspects of skin and facial aging in a single step: supporting natural regeneration, sustainably improving skin tone, texture, and facial contours – with minimal downtime.

It can also be applied in hair loss treatment and scar improvement.

This innovation allows for more sustainable aesthetic medicine – with minimal material use and maximum effect.

The procedure is based on over seven years of clinical experience and multiple award-nominated cases (AMWC Aesthetic Medicine Awards 2024 & 2025).

Why a patent application?

The patent application is not intended to restrict access, but to ensure responsible, consistent use – exclusively by trained physicians.

This ensures patient safety, quality standards, and professional integrity.

For physicians – License & Training

Physicians can learn the method through our Academy.

The “Dr. Dragieva Nanofat Protocol – Patent Pending” online course includes:


Register today

For patients – Consultation & Treatment

Patients benefit from an innovative, autologous treatment with natural results and short downtime.

We provide an individual consultation to determine if the procedure is suitable for their skin or hair concerns.